前日（2月7日）， 全球骨科手术机器人龙头企业Globus Medical（NYSE: GMED）宣布以每股5.85美元的价格收购慢性疼痛治疗公司Nevro（NYSE: NVRO）全部股份，总股权价值达2.5亿美元（约合18.2亿元人民币） 。这一价格较Nevro过去90天的平均股价溢价27%，较30天平均股价溢价38%，交易预计于2025年第二季度末完成。

Globus Medical, a leading musculoskeletal solutions company, has announced its acquisition of Nevro Corp, a global medical ...

Globus Medical (NYSE:GMED) announced today that it agreed to acquire chronic pain treatment developer Nevro (NYSE:NVRO).

Globus Medical (NYSE: GMED) has announced a definitive agreement to acquire all shares of Nevro Corp. (NYSE: NVRO) in an ...

Analysts said Nevro’s valuation was “inexpensive,” but the spinal cord stimulation business can benefit from Globus’ scale ...

NOT ALL LAW FIRMS ARE THE SAME. Before you hire a law firm, you should talk to a lawyer and ask: When was the last time you recovered money for shareholders?

Globus will buy all outstanding Nevro shares for $5.85 per share under the terms of the agreement, therefore reflecting a 27% ...

另一方面，Canaccord Genuity在公司公布2024年第四季度强劲初步业绩后，维持对Globus Medical的买入评级，并将目标价上调至101美元。Truist Securities虽然认可公司的优势，但维持对Globus Medical的持有评级，等待进一步的收入和每股收益增长证据。这些最新进展反映了公司的增长轨迹和Nevro Corp收购预期带来的收益。

Globus Medical (GMED), a musculoskeletal solutions company, Thursday agreed to acquire Nevro Corp. (NVRO), a medical device company, ...

Montgomery County's Globus Medical has agreed to acquire a California life sciences company focused on treating chronic pain ...

BTIG says Globus Medical’s (GMED) announced acquisition of Nevro (NVRO) “is surprising on the surface.” Investors did not expect Globus would ...